BDBM492055 4-((S)-4,4-Difluoro-2-methylpyrrolidine-1-carbonyl)-N—((R)-3-hydroxy-3-methylbutan-2-yl)-5-(6-((1-methhylcyclobutyl)amino)-4-(trifluoromethyl)pyridine-3-yl)thiazole-2-carboxamide::US10975068, Example 196

SMILES C[C@@H](NC(=O)c1nc(C(=O)N2CC(F)(F)C[C@@H]2C)c(s1)-c1cnc(NC2(C)CCC2)cc1C(F)(F)F)C(C)(C)O

InChI Key InChIKey=PPGSSVKOTGAMDS-UHFFFAOYSA-N

Data  1 Kd

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 1 hit for monomerid = 492055   

TargetNuclear receptor ROR-gamma(Human)
Janssen Pharmaceutica

US Patent
LigandPNGBDBM492055(US10975068, Example 196 | 4-((S)-4,4-Difluoro-2-me...)
Affinity DataKd:  0.640nMAssay Description:1,8-ANS (Invitrogen) was used as a fluorescent dye. Protein and compound solutions are dispensed into black 384-well polypropylene PCR microplates (A...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/20/2021
Entry Details
Go to US Patent